100 related articles for article (PubMed ID: 25389904)
1. Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.
Piwowarczyk K; Wybieralska E; Baran J; Borowczyk J; Rybak P; Kosińska M; Włodarczyk AJ; Michalik M; Siedlar M; Madeja Z; Dobrucki J; Reiss K; Czyż J
Expert Opin Ther Targets; 2015 Feb; 19(2):163-76. PubMed ID: 25389904
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.
Wybieralska E; Szpak K; Górecki A; Bonarek P; Miękus K; Drukała J; Majka M; Reiss K; Madeja Z; Czyż J
Oncol Rep; 2011 Aug; 26(2):447-53. PubMed ID: 21617875
[TBL] [Abstract][Full Text] [Related]
3. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling.
Piwowarczyk K; Kwiecień E; Sośniak J; Zimoląg E; Guzik E; Sroka J; Madeja Z; Czyż J
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30274176
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
[TBL] [Abstract][Full Text] [Related]
7. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
Grabacka M; Plonka PM; Urbanska K; Reiss K
Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
[TBL] [Abstract][Full Text] [Related]
10. Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.
Liu X; Yan Z; Huang L; Guo M; Zhang Z; Guo C
Oncol Rep; 2011 May; 25(5):1343-51. PubMed ID: 21369706
[TBL] [Abstract][Full Text] [Related]
11. Analysis of PPARalpha-dependent and PPARalpha-independent transcript regulation following fenofibrate treatment of human endothelial cells.
Araki H; Tamada Y; Imoto S; Dunmore B; Sanders D; Humphrey S; Nagasaki M; Doi A; Nakanishi Y; Yasuda K; Tomiyasu Y; Tashiro K; Print C; Charnock-Jones DS; Kuhara S; Miyano S
Angiogenesis; 2009; 12(3):221-9. PubMed ID: 19357976
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells.
Yang S; Yip R; Polena S; Sharma M; Rao S; Griciene P; Gintautas J; Jerome H
Proc West Pharmacol Soc; 2004; 47():54-6. PubMed ID: 15633612
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.
Zhao H; Zhu C; Qin C; Tao T; Li J; Cheng G; Li P; Cao Q; Meng X; Ju X; Shao P; Hua L; Gu M; Yin C
Biochem Biophys Res Commun; 2013 Mar; 432(2):320-5. PubMed ID: 23399562
[TBL] [Abstract][Full Text] [Related]
14. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
15. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
17. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
[TBL] [Abstract][Full Text] [Related]
18. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
[TBL] [Abstract][Full Text] [Related]
19. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
Lacoste J; Aprikian AG; Chevalier S
Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
